Does fluoxetine reduce apathetic and depressive symptoms after stroke? An analysis of the Efficacy oF Fluoxetine-a randomized Controlled Trial in Stroke trial data set.
Jonathan Taynull nullBjörn MårtenssonHugh Stephen MarkusErik LundströmPublished in: International journal of stroke : official journal of the International Stroke Society (2022)
Post-stroke apathetic and depressive symptoms respond differently to fluoxetine treatment. Our analysis suggests fluoxetine is ineffective in preventing post-stroke apathy.
Keyphrases
- depressive symptoms
- social support
- atrial fibrillation
- clinical trial
- study protocol
- sleep quality
- electronic health record
- phase iii
- phase ii
- randomized controlled trial
- big data
- physical activity
- machine learning
- blood brain barrier
- open label
- artificial intelligence
- brain injury
- cerebral ischemia
- deep learning
- replacement therapy
- combination therapy